Pfizer – Addressing the Needs of Patients with Mental Health Issues and Dermatological Inflammatory Conditions – RFP

Well-being, Health and Biomedical Discovery


Academic Unit: Inquire within unit

Memorial Deadline: Monday 1st, May 2023

External Deadline: Monday 8th, May 2023


Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the practice gaps as outlined in the specific RFP.

For all independent quality improvement grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct or monitoring of the quality improvement program.

Date RFP Issued: February 14, 2023

Geographic Scope: Canada

Clinical Area: Atopic Dermatitis, Alopecia Areata, and other inflammatory conditions such as Vitiligo, Psoriasis, and Hidradenitis suppurativa

Link to full RFP: Addressing the Needs of Patients with Mental Health Issues and Dermatological Inflammatory Conditions

Application Due Date: May 8, 2023

Specific Area of Interest: Projects that will be considered for Pfizer support will improve the quality of mental health care of patients with dermatologic inflammatory conditions with a focus including, but not limited to, any of the following:

  • Early assessment and diagnosis of mental health issues in patients dealing with a dermatological inflammatory condition
  • Supporting collaboration among health care providers within a multidisciplinary team environment to improve patient management
  • Implementing health care technologies (mobile or web-based tools) for telehealth and remote monitoring
  • Identifying and addressing the needs of patients with mental health issues in rural, remote, and indigenous populations
  • Improving and helping advance already established coordinated partnerships with local organizations and local community healthcare centers to better address mental health issues of AD/ AA patients
Refer to complete details in the full RFP document. If you have questions regarding this RFP, please direct them in writing to Beth Brillinger, Grant Officer (


Funding Sources

Pfizer Inc

This opportunity was posted by: RGCS

Last modified: February 15, 2023